AlternativeMed
Relationship Graph Explorer

Follow the connections

Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.

Plus 6,743 TCM formulas connecting herbs together
🏥 Disease / Health Topic

Gastric Adenocarcinoma

18
Clinical Trials
3
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT02013154
A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab
Completed · Phase 1
NCT02370498
A Study of Pembrolizumab (MK-3475) Versus Paclitaxel for Participants With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma That Progressed After Therapy With Platinum and Fluoropyrimidine (MK-3475-061/KEYNOTE-061)
Completed · Phase 3
NCT02514551
A Study of Ramucirumab (LY3009806) in Combination With Paclitaxel in Participants With Gastric Cancer
Completed · Phase 2
📊 Sample Meta-Analyses
CRD42016032668
Non-bismuth concomitant quadruple therapy for Helicobacter pylori eradication in the Chinese region: a meta-analysis of randomized controlled trials
Helicobacter pylori infection has been proved to be the major cause of chronic g
CRD42022295372
Systematic Review and Meta-analysis of 10 and 14 days Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication
Helicobacter pylori (H.pylori) infection is a common global infectious disease a
CRD42019125419
Banxia xiexin decoction for patients with peptic ulcer or chronic gastritis infected with helicobacter pylori: a systematic review of randomized controlled trials
Helicobacter pylori (H. pylori) causes a serious, chronic, infectious disease th
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Gastric Adenocarcinoma
🏥 Names
Disease Name
Gastric Adenocarcinoma
Alias Names
Gastric Adenocarcinoma
Topic Type
disease
🧬 Ontology Classifications
DisGeNET Type
disease
UMLS Type
Neoplastic Process
MeSH Class
Digestive System Diseases; Neoplasms
DO Class
disease of anatomical entity; disease of cellular proliferation
🔗 External References
Disease Ontology
3717
DisGeNET
C0278701
🔍 Raw view — every non-empty column on this row (25 fields)
name
Gastric Adenocarcinoma
alias name
Gastric Adenocarcinoma
topic type
disease
disgenet disease type
disease
umls disease type
Neoplastic Process
mesh disease class
Digestive System Diseases; Neoplasms
do disease class
disease of anatomical entity; disease of cellular proliferation
umls disease type id
T191
mesh disease class id
C04; C06
do disease class id
DOID:14566; DOID:7
herb disease id
HBDIS006998
disgenet id
C0278701
do id
3717

⚗️ Related Ingredients

2 · compounds in this herb

📋 Clinical Trials

12 · subject of clinical study
NCT02013154 A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab
→ Esophageal Neoplasms|Adenocarcinoma of the Gastroe
NCT02370498 A Study of Pembrolizumab (MK-3475) Versus Paclitaxel for Participants With Advan
→ Gastric Adenocarcinoma|Gastroesophageal Junction A
NCT02514551 A Study of Ramucirumab (LY3009806) in Combination With Paclitaxel in Participant
→ Gastric Adenocarcinoma|Gastroesophageal Junction A
NCT02615730 PI3Kβ Selective Inhibitor With Paclitaxel, Advanced Gastric Adenocarcinoma
→ Advanced Gastric Adenocarcinoma
NCT02628951 Ramucirumab/Paclitaxel as Second-line Treatment in Metastatic Gastric or Gastroe
→ Gastric Adenocarcinoma|Gastroesophageal Junction A
NCT02898077 A Study of Paclitaxel With or Without Ramucirumab (LY3009806) in Participants Wi
→ Gastroesophageal Junction Adenocarcinoma|Gastric A
NCT03193918 Study of Crenolanib With Ramucirumab and Paclitaxel for Advanced Esophagogastric
→ Esophagogastric Adenocarcinoma
NCT04034251 Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine f
→ Gastric Adenocarcinoma|Gastric Cancer|Esophagogast
NCT04047953 Paclitaxel (Albumin-bound) Combined With Oxaliplatin and S-1 Conversion Therapy
→ Gastric Adenocarcinoma
NCT04209686 Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Ad
→ Advanced Gastric Adenocarcinoma
NCT04220827 Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer
→ Clinical Stage IV Gastric Cancer AJCC v8|Clinical
NCT04499924 Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramuci
→ Gastric Adenocarcinoma|Gastroesophageal Junction A

📊 Meta-Analyses

3 · systematic review
CRD42016032668 Non-bismuth concomitant quadruple therapy for Helicobacter pylori eradication in
→ Helicobacter pylori infection has been proved to b
CRD42022295372 Systematic Review and Meta-analysis of 10 and 14 days Bismuth-containing Quadrup
→ Helicobacter pylori (H.pylori) infection is a comm
CRD42019125419 Banxia xiexin decoction for patients with peptic ulcer or chronic gastritis infe
→ Helicobacter pylori (H. pylori) causes a serious,
How relationships are computed
  • Clinical Trials / Meta-Analyses / References: direct foreign-key link via subject_entity_id (Phase 2d wireup)
  • Formula ↔ Herbs: text bridge via formulas.herbs_in_pinyin matching herbs.pinyin_name
  • Herb ↔ Ingredient: ACTIVE — direct link via herb_ingredients
  • Ingredient ↔ Target: ACTIVE — direct link via ingredient_targets
  • Target ↔ Disease: ACTIVE — direct link via target_health_topics
  • Herb → Target → Disease (full chemical spine): ACTIVE — joins all three link tables